Search

everythinglearnresearchcommunity

for

Search:↓

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

The new face mask with Eflornithine can potentially reduce facial hair growth and moisturize skin.